Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor

Pulsenmore Ltd. has announced a significant fundraising initiative, entering into a securities purchase agreement for a private placement valued at $7.5 million with a healthcare-focused institutional investor. The transaction, which involves the purchase and sale of 1,562,500 ordinary shares and accompanying warrants, is expected to close on or about June 26, 2026. The gross proceeds from this offering are anticipated to be approximately $7.5 million before deducting placement agent commissions and other related expenses.

Pulsenmore, headquartered in Ramat Gan, Israel, is recognized for its innovative contributions to home ultrasound technology, particularly in the realm of maternal health. The company aims to enhance prenatal care by enabling remote connections between mothers and healthcare providers through advanced imaging and telemedicine solutions. This approach not only makes prenatal care more patient-centric but also expands access and improves the continuity of care, which is crucial for expectant mothers and their families.

The strategic rationale behind this fundraising effort is to bolster Pulsenmore's commercial footprint, particularly in the U.S. market, and to increase market penetration. The proceeds from the offering are intended to support marketing and commercialization activities, working capital needs, and other general corporate purposes. The issuance of ordinary warrants with an exercise price of $4.80 per share, which are immediately exercisable, reflects the company's confidence in its growth trajectory and market potential. This financing is expected to facilitate the execution of strategic initiatives designed to drive long-term growth and enhance shareholder value.

The healthcare sector, particularly in the area of maternal health technology, is experiencing significant transformation driven by advancements in telemedicine and remote monitoring solutions. As more healthcare providers and patients embrace digital health solutions, companies like Pulsenmore are well-positioned to capitalize on this trend. The increasing demand for accessible and efficient healthcare services is likely to propel further investments in innovative healthcare technologies.

In summary, Pulsenmore's $7.5 million private placement underscores the growing interest in healthcare technology and the potential for innovation in maternal health. As the company prepares to utilize these funds for expansion and commercialization efforts, it may also set a precedent for future investments in the sector. The successful execution of this fundraising initiative could enhance Pulsenmore's competitive position and contribute positively to the broader healthcare landscape, where patient-centric solutions are becoming increasingly vital.